A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec

NCT00250042 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Other
Cancer

Interventions

DRUG: Gleevec and Arsenic Trioxide

Sponsor

New Mexico Cancer Research Alliance